- About Us
- Services & Solutions
- Services by Functionality
- Services by Development Stage
- Proprietary Technologies
- Specialized Expertise
- Quality & Compliance
- Insights & Resources
- News & Events
At MedPharm, we recognize that clinical supply goes beyond logistics—it’s a vital component in proving the viability, safety, and efficacy of your drug product. Our Clinical Supply Services provide comprehensive support for topical and transdermal clinical programs, ensuring that your investigational therapies are manufactured, tested, and delivered with precision and compliance.
Whether you’re preparing for a Phase I study or finalizing your registration batches, MedPharm delivers clinical materials with the care, speed, and regulatory readiness that high-stakes trials require.
Your clinical trial depends on the availability, consistency, and quality of your investigational product. MedPharm delivers—with science, structure, and speed.
We offer a flexible, scalable, and fully GMP-compliant clinical supply infrastructure tailored to the unique needs of semisolid and transdermal drug products. Our integrated teams streamline the transition from formulation through clinical production to commercial planning.
Explore Our Clinical Supply Capabilities below.
GMP-compliant manufacturing of investigational drug products (IMPs) for Phase I–III trials. Our scalable, repeatable processes are designed for consistency, compliance, and audit readiness.
Our manufacturing process emphasizes precision and compliance, integrated with QA oversight and global regulatory alignment to ensure that investigational drug products are delivered without compromise.
We support pivotal registration batches, including Process Performance Qualification (PPQ) and validation studies, designed to meet regulatory requirements and ensure commercial readiness.
We bridge lab-scale formulations and clinical-scale production using proven strategies for process adaptation, equipment alignment, and formulation robustness.
